SCHEMBL3939874

SCHEMBL3939874

CN1CCN(c2ccc(/C(=C/C=C/C(=O)Nc3cccc4cnccc34)c3ccc(C(F)(F)F)cc3)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 19/20 0.49
▸ NPY5R Q15761 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3939879 1.00 TRPV1 (0.49) TRPV1NPY5R
SCHEMBL3939870 1.00 TRPV1 (0.49) TRPV1NPY5R
SCHEMBL3939605 0.93 TRPV1 (0.52) TRPV1
SCHEMBL3939600 0.93 TRPV1 (0.52) TRPV1
SCHEMBL3939602 0.93 TRPV1 (0.52) TRPV1
Hydrochloric Acid SCHEMBL3941619 0.91 TRPV1 (0.52) TRPV1
Hydrochloric Acid SCHEMBL3941621 0.91 TRPV1 (0.52) TRPV1
Hydrochloric Acid SCHEMBL3941623 0.91 TRPV1 (0.52) TRPV1
SCHEMBL3941246 0.91 TRPV1 (0.53) TRPV1
SCHEMBL3941243 0.91 TRPV1 (0.53) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203667-A1 PENTADIENAMIDE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-08-13 — — US disclosed
EP-2050734-A1 PENTADIENAMIDE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2009-04-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203667-A1 PENTADIENAMIDE DERIVATIVES PRMT1, REN, NGLY1 TRPV1 2741/4885NPY5R 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback